[A new aspect in the research on antiepileptic drugs].
Miura
Yoshiki
Y
yoshiki-miura@ds-pharma.co.jp
D000081:Acetamides; D000588:Amines; D000818:Animals; D000927:Anticonvulsants / Q000737:chemistry / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D001569:Benzodiazepines; D002219:Carbamates; D003509:Cyclohexanecarboxylic Acids; D004195:Disease Models, Animal; D015195:Drug Design; D000077206:Gabapentin; D006801:Humans; D000078334:Lacosamide; D000077287:Levetiracetam; D010655:Phenylenediamines; D010889:Piracetam / Q000031:analogs & derivatives; D000069583:Pregabalin; D011280:Pregnanolone / Q000031:analogs & derivatives; D011760:Pyrrolidinones; D014230:Triazoles; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives
D000081:Acetamides; D000588:Amines; D000927:Anticonvulsants; D002219:Carbamates; D003509:Cyclohexanecarboxylic Acids; D010655:Phenylenediamines; D011760:Pyrrolidinones; D014230:Triazoles; D001569:Benzodiazepines; C101866:ezogabine; D000077287:Levetiracetam; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000078334:Lacosamide; D000077206:Gabapentin; C105051:ganaxolone; D011280:Pregnanolone; C085266:talampanel; C482793:brivaracetam; C079703:rufinamide; D010889:Piracetam